BreezeBio
Entity

  • BreezeBio

    Created in 2016


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    4,537 131

  • Activities

    biotech deeptech nanotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    3000 Marina Blvd suite 350, Brisbane, CA 94005, USA

    Brisbane

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 65

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    6 years, 7 months ago
Description
  • Value proposition

    Genetic Medicine Delivered

    BreezeBio is a biotechnology company developing precision genetic medicines enabled by targeted, non-viral delivery across biologically relevant tissues. Using our proprietary NanoGalaxy® platform, we engineer nanoparticles designed to deliver genetic payloads, including mRNA, to specific cell types. Our platform has demonstrated delivery to immune cells as well as select tissues in the heart, lung, and central nervous system. We are advancing an internal therapeutic pipeline focused on autoimmune diseases and oncology. Our lead program, BRZ-101, is designed to restore immune tolerance in type 1 diabetes and is advancing into IND-enabling studies. BreezeBio is headquartered in the South San Francisco area.

Catalyst interactions
Catalyst Type Tweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles